histotripsy
-
February 19, 2026
Zhen Xu named one of Time’s 100 most influential health leaders
Co-inventor of the non-invasive, tumor-eliminating treatment called histotripsy, Professor Zhen Xu, was named among the Time 100 Most Influential Health Leaders for 2026.
-
February 19, 2026
Two U-M engineers recognized by Sony and Nature
Two of the three recipients of the second-ever Sony Women in Technology Award with Nature are from the College of Engineering.
-
August 25, 2025
Q&A: Tumor-destroying histotripsy, explained by its inventor
The acquisition of HistoSonics will enable histotripsy, the revolutionary, non-invasive technique for destroying tumors developed at U-M, to reach more potential patients than ever before.
-
August 8, 2025
Accolades — August 2025
Awards and honors for faculty and staff from across U-M.
-
August 8, 2025
U-M startup HistoSonics announces $2.25B acquisition
HistoSonics, a U-M startup founded in 2009, announced a $2.25 billion acquisition, joining a short list of companies stemming from the university that have reached billion-dollar status.
-
June 6, 2025
U-M researchers aim to expand use of histotripsy to fight cancers
As the use of histotripsy is expanding across the state of Michigan and to surrounding states, U-M researchers are continuously observing the body’s immune response to histotripsy treatment.
-
October 9, 2023
FDA approves histotripsy for liver treatment in humans
The U.S. Food and Drug Administration has approved the use of sound waves to break down tumors — a technique called histotripsy, which was pioneered at U-M — in humans for liver treatment.
